Autolus Therapeutics plc Total Liabilities

Autolus Therapeutics plc (AUTL) currently reports a total liabilities of $420M as of March 2026. That compares with $380M in the prior-year period — up 11.5% year over year. Use the charts on this page to explore Autolus Therapeutics plc's total liabilities history and peer comparisons.

Autolus Therapeutics plc's total liabilities increased from $380M to $420M — a 11.5% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Autolus Therapeutics plc reported $420M in total liabilities as of March 2026. That compares with $380M in the prior-year period — up 11.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $420M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Autolus Therapeutics plc, and consider following AUTL for alerts when major investors trade the stock.

Autolus Therapeutics plc is classified in the Healthcare sector. On total liabilities, it currently shows $420M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AUTL with unrelated industries.